Cepheid launches GeneXpert in molecular clinical research

Oct. 26, 2005 – Cepheid announced the launch of the GeneXpert System into the molecular clinical research field. The initial product for use on the GeneXpert System in this field is a research product for the identification of cells carrying the BCR/ABL chromosomal translocation.

This company says the application is for research only and is not for use in diagnostic procedures. The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with chronic myelogenous leukemia. Both the GeneXpert system and the BCR/ABL product will be available for shipment on a research-use-only basis starting on November 15.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.